Credit Suisse analyst Alethia Young lifted her price target on Ascendis Pharma (Nasdaq: ASND) from $30.00 to $50.00 sending the stock price soaring $6.50 to close at $34.24.
Price target lifted on Ascendis Pharma
September 22, 2017 at 19:13 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.